BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35864588)

  • 21. DDX24 promotes tumor progression by mediating hexokinase-1 induced glycolysis in gastric cancer.
    Ni Y; Zhuang Z
    Cell Signal; 2024 Feb; 114():110995. PubMed ID: 38043669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ETS-1 Induces Endothelial-Like Differentiation and Promotes Metastasis in Non-Small Cell Lung Cancer.
    Zhou X; Zhou R; Zhou H; Li Q; Hong J; Meng R; Zhu F; Zhang S; Dai X; Peng G; Wu G; Li Z
    Cell Physiol Biochem; 2018; 45(5):1827-1839. PubMed ID: 29510376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer.
    He D; Wang J; Zhang C; Shan B; Deng X; Li B; Zhou Y; Chen W; Hong J; Gao Y; Chen Z; Duan C
    Mol Cancer; 2015 Apr; 14():73. PubMed ID: 25889562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EVI5 is an oncogene that regulates the proliferation and metastasis of NSCLC cells.
    Cai T; Zhou J; Zeng Y; Du W; Zhang Y; Liu T; Fu Y; Huang JA; Qian Q; Zhu J; Ling C; Liu Z
    J Exp Clin Cancer Res; 2020 May; 39(1):84. PubMed ID: 32393392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. lncRNA BCAR4 Increases Viability, Invasion, and Migration of Non-Small Cell Lung Cancer Cells by Targeting Glioma-Associated Oncogene 2 (
    Yang H; Yan L; Sun K; Sun X; Zhang X; Cai K; Song T
    Oncol Res; 2019 Feb; 27(3):359-369. PubMed ID: 29615150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circular RNA circ_0003028 contributes to tumorigenesis by regulating GOT2 via miR-1298-5p in non-small cell lung cancer.
    Guan H; Sun C; Gu Y; Li J; Ji J; Zhu Y
    Bioengineered; 2021 Dec; 12(1):2326-2340. PubMed ID: 34077306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SRPX2 promotes cell proliferation and invasion via activating FAK/SRC/ERK pathway in non-small cell lung cancer.
    Li X; Liu J; Sun H; Zou Y; Chen J; Chen Y; Chen C; Wu X
    Acta Biochim Pol; 2020 Jun; 67(2):165-172. PubMed ID: 32550700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 30. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.
    Chen W; Wang J; Liu S; Wang S; Cheng Y; Zhou W; Duan C; Zhang C
    J Exp Clin Cancer Res; 2016 May; 35():76. PubMed ID: 27164951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncRNA HOXC-AS3 promotes non-small-cell lung cancer growth and metastasis through upregulation of YBX1.
    Su H; Fan G; Huang J; Qiu X
    Cell Death Dis; 2022 Apr; 13(4):307. PubMed ID: 35387975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NT5DC2 suppression restrains progression towards metastasis of non-small-cell lung cancer through regulation p53 signaling.
    Jin X; Liu X; Zhang Z; Xu L
    Biochem Biophys Res Commun; 2020 Dec; 533(3):354-361. PubMed ID: 32962856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metformin-repressed miR-381-YAP-snail axis activity disrupts NSCLC growth and metastasis.
    Jin D; Guo J; Wu Y; Chen W; Du J; Yang L; Wang X; Gong K; Dai J; Miao S; Li X; Su G
    J Exp Clin Cancer Res; 2020 Jan; 39(1):6. PubMed ID: 31906986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-1204 promotes cell proliferation by regulating PITX1 in non-small-cell lung cancer.
    Jiang W; He Y; Shi Y; Guo Z; Yang S; Wei K; Pan C; Xia Y; Chen Y
    Cell Biol Int; 2019 Mar; 43(3):253-264. PubMed ID: 30549141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Silencing of Long Non-Coding RNA FGD5-AS1 Inhibits the Progression of Non-Small Cell Lung Cancer by Regulating the miR-493-5p/DDX5 Axis.
    Cui F; Luo P; Bai Y; Meng J
    Technol Cancer Res Treat; 2021; 20():1533033821990007. PubMed ID: 33550957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long non-coding RNA SNHG6 promotes the growth and invasion of non-small cell lung cancer by downregulating miR-101-3p.
    Li K; Jiang Y; Xiang X; Gong Q; Zhou C; Zhang L; Ma Q; Zhuang L
    Thorac Cancer; 2020 May; 11(5):1180-1190. PubMed ID: 32147945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PHB2 promotes tumorigenesis
    Wu B; Chang N; Xi H; Xiong J; Zhou Y; Wu Y; Wu S; Wang N; Yi H; Song Y; Chen L; Zhang J
    Theranostics; 2021; 11(7):3150-3166. PubMed ID: 33537079
    [No Abstract]   [Full Text] [Related]  

  • 38. FOXP3 promotes tumor growth and metastasis by activating Wnt/β-catenin signaling pathway and EMT in non-small cell lung cancer.
    Yang S; Liu Y; Li MY; Ng CSH; Yang SL; Wang S; Zou C; Dong Y; Du J; Long X; Liu LZ; Wan IYP; Mok T; Underwood MJ; Chen GG
    Mol Cancer; 2017 Jul; 16(1):124. PubMed ID: 28716029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long noncoding RNA OSER1‑AS1 promotes the malignant properties of non‑small cell lung cancer by sponging microRNA‑433‑3p and thereby increasing Smad2 expression.
    Liu X; Huang S; Guan Y; Zhang Q
    Oncol Rep; 2020 Aug; 44(2):599-610. PubMed ID: 32627026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-7-5p suppresses tumor metastasis of non-small cell lung cancer by targeting NOVA2.
    Xiao H
    Cell Mol Biol Lett; 2019; 24():60. PubMed ID: 31832068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.